These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 361420)

  • 21. The effect of PGI2 and PGI2 analogues with increased stability on platelet cAMP content and aggregation.
    Blaskó G; Nemesánszky E; Szabó G; Stadler I; Pálos LA
    Thromb Res; 1980 Mar; 17(5):673-81. PubMed ID: 6247777
    [No Abstract]   [Full Text] [Related]  

  • 22. Coronary vasodilation: interactions between prostacyclin and adenosine.
    Blass KE; Förster W; Zehl U
    Br J Pharmacol; 1980 Aug; 69(4):555-9. PubMed ID: 7002243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction between prostacyclin and nitric oxide in the reflex control of the coronary circulation in conscious dogs.
    Zhao G; Xu X; Ochoa M; Shen W; Hintze TH
    Cardiovasc Res; 1996 Nov; 32(5):940-8. PubMed ID: 8944825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular actions of arachidonic acid and its metabolites in perfused mesenteric and femoral beds of the dog.
    Dusting GJ; Moncada S; Vane JR
    Eur J Pharmacol; 1978 May; 49(1):65-72. PubMed ID: 350595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of the chronotropic effects of prostacyclin in the dog: comparison with the actions of prostaglandin E2.
    Chiba S; Malik KU
    J Pharmacol Exp Ther; 1980 May; 213(2):261-6. PubMed ID: 6988574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Action of prostacyclin (PGI2) and prostaglandin E2 (PGE2) on gastric secretion and mucosal blood flow in dogs.
    Konturek SJ
    Gastroenterology; 1980 Jul; 79(1):182-4. PubMed ID: 6991360
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of low dose prostacyclin infusion on blood flow in acutely ischemic canine myocardium.
    Einzig S; Sotomora R; Rao GH; Gerrard JM; Foker JE; White JG
    Prostaglandins Med; 1980 Sep; 5(3):209-19. PubMed ID: 6997909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. dl-9a-Deoxy-9a-methylene-PGI2 (a stable prostacyclin derivative): preliminary pharmacological data.
    Ceserani R; Grossoni M; Longiave D; Mizzotti B; Pozzi O; Dembinska-Kiec A; Bianco S
    Prostaglandins Med; 1980 Aug; 5(2):131-9. PubMed ID: 6251496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of prostacyclin on coronary occlusion induced arrhythmia in cats.
    Dix RK; Kelliher GJ; Jurkiewicz N; Lawrence T
    Prostaglandins Med; 1979 Sep; 3(3):173-84. PubMed ID: 399533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Some cardiovascular properties of prostacyclin (PGI2) which are not shared by PGE2.
    Dusting GJ; Vane JR
    Circ Res; 1980 Jun; 46(6 Pt 2):I183-7. PubMed ID: 6991150
    [No Abstract]   [Full Text] [Related]  

  • 31. Bronchodilator effects of prostacyclin (PGI2) in dogs and guinea pigs.
    Wasserman MA; Ducharme DW; Wendling MG; Griffin RL; Degraaf GL
    Eur J Pharmacol; 1980 Aug; 66(1):53-63. PubMed ID: 6997057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The renal haemodynamic and excretory actions of prostacyclin (PGI2) in anaesthetized dogs [proceedings].
    Hill TW; Moncada S
    Br J Pharmacol; 1978 Mar; 62(3):413P-414P. PubMed ID: 346131
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of prostacyclin (PGI2), PGI1 and 6-oxo-PGF1alpha on the rat gastric mucosa [proceedings].
    Boughton-Smith NK; Vane JR; Whittle BJ
    Br J Pharmacol; 1978 Mar; 62(3):413P. PubMed ID: 346130
    [No Abstract]   [Full Text] [Related]  

  • 34. Prostacyclin and prostaglandin E2 effects on adrenergic transmission in the kidney of anesthetized dog.
    Susić H; Malik KU
    J Pharmacol Exp Ther; 1981 Sep; 218(3):588-92. PubMed ID: 6167710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of prostacyclin and a stable analogue, 6-beta-PGI1, on gastric acid secretion, mucosal blood flow, and blood pressure in conscious dogs.
    Kauffman GL; Whittle BJ; Aures D; Vane JR; Grossman MI
    Gastroenterology; 1979 Dec; 77(6):1301-6. PubMed ID: 387511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of epoprostenol (prostacyclin, PGI2) on cerebral blood flow in man.
    Brown MM; Pickles H
    J Neurol Neurosurg Psychiatry; 1982 Nov; 45(11):1033-6. PubMed ID: 6816907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostacyclin produced by the pregnant uterus in the dog may act as a circulating vasodepressor substance.
    Gerber JG; Payne NA; Murphy RC; Nies AS
    J Clin Invest; 1981 Mar; 67(3):632-6. PubMed ID: 7009646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 6-Keto-prostaglandin E1 is more potent than prostaglandin I2 as a renal vasodilator and renin secretagogue.
    Jackson EK; Herzer WA; Zimmerman JB; Branch RA; Oates JA; Gerkens JF
    J Pharmacol Exp Ther; 1981 Jan; 216(1):24-7. PubMed ID: 7005428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of prostacyclin (PGI2) in metabolic hyperemia.
    Fondacaro JD; Jacobson ED
    Prostaglandins; 1981; 21 Suppl():25-32. PubMed ID: 7029651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epoprostenol (prostacyclin,PGI2) increases apparent liver blood flow in man.
    Hassan S; Pickles H
    Prostaglandins Leukot Med; 1983 Apr; 10(4):449-54. PubMed ID: 6344102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.